Podcast Summary: Strengthening Health System Specialty Pharmacy Strategies

Podcast: Becker’s Healthcare Podcast
Guest: Eric Huckins, PharmD, VP Pharmacy, Lumicera Health Services (SSM Health)
Host: Brian Zerman
Date: November 17, 2025

Episode Overview

This episode focuses on strategies for strengthening health system specialty pharmacy capabilities, featuring insights from Eric Huckins of Lumicera Health Services. The conversation covers current trends in specialty pharmacy, the impact of policy and financial pressures, technological innovation, the importance of partnerships, and what’s on the horizon for Lumicera and the industry.

Key Themes & Discussion Points

1. Background and Role of Lumicera Health Services

[00:21–01:48]

• Eric Huckins describes his career and Lumicera's mission:
  • Pharmacist by training, VP of business development.
  • Lumicera is health system-owned (majority by SSM Health, with Navitus, a transparent PBM, as an owner).
  • Focused on supporting health systems nationally with specialty pharmacy services, 340B initiatives, and technology enablement.
  • “We’ve had immense growth... over $5 billion in traditional specialty spend. That’s given us the size and scale to help other health systems grow.” (B, 01:21)

2. Industry Trends: Growth of Specialty Pharmacy and Direct-to-Consumer Models

[01:48–03:52]

• Specialty drugs dominate the pipeline, especially in infusion, cell, and gene therapy.
• Shift in patient therapies from infusions to self-injectables; Lumicera helps health systems manage the entire patient journey.
• Rise of direct-to-consumer models:
  • Transparency and cost reduction are key.
  • The patient pharmacy experience must stay at the forefront—size, scale, and payer/manufacturer relations are essential.
• “What isn’t fluff is really the pharmacy patient experience.” (B, 02:56)

3. Navigating Policy & Financial Headwinds

[03:52–05:24]

• The Inflation Reduction Act (IRA), rebate changes, and Medicaid funding shifts present major challenges.
• Few health systems are fully prepared for upcoming IRA implementation.
• Collaboration within the industry is vital:
  • Data analytics are crucial for understanding and adapting to policy impacts.
  • Lumicera provides partners with advanced analytics to anticipate effects on 340B and specialty pharmacy performance.
• “If you’re a health system and you don’t have a work group or impact analysis completed at this point of the year with the IRA coming up, you’ve got your work cut out for you.” (B, 04:30)

4. Concrete Examples of Lumicera’s Work with Health Systems

[05:24–06:30]

• Focusing on the IRA’s MFP-priced drug list, especially three specialty products.
• Assisting health systems in deep dives on utilization, prescribers, and care team coordination.
• Preparing now for the 2026 and 2027 IRA drug lists—building lasting infrastructure for ongoing policy changes.
• “What we build now will resonate for future years as this model is really here to stay.” (B, 06:17)

5. Technological Integration and Future Opportunities

[06:53–09:07]

• Major investments in technology interoperability and AI to streamline specialty pharmacy workflows.
• Emphasis on systems integration to prevent care fragmentation and improve patient access.
• Growth in home infusion services as boundaries blur between infused, injectable, and home care.
• Insurance complexities and benefit designs are increasing; Lumicera leverages PBM ownership to aid partner health systems.
• “AI can only do so much unless it’s integrated... That’s really where we see some of the future of letting the technology do some of the work.” (B, 07:06)
• “The lines have really blurred... at the end of the day it’s all pharmacy.” (B, 08:09)

6. The Case for Strong Partnerships

[09:07–10:22]

• Importance of working with partners who understand health system incentives and have the necessary size and scale.
• Collaboration accelerates innovation and success.
• “To maximize success and speed to innovation, you need to find a strong partner...aligned incentives with both the health system and the patient.” (B, 09:35)
• Advocates for event networking (like Becker’s Summit) to find strategic partners.

Notable Quotes & Memorable Moments

• “What isn’t fluff is really the pharmacy patient experience.” (Eric Huckins, 02:56)
• “If you’re a health system and you don’t have a work group or impact analysis completed at this point of the year with the IRA coming up, you’ve got your work cut out for you.” (Eric Huckins, 04:30)
• “What we build now will resonate for future years as this model is really here to stay.” (Eric Huckins, 06:17)
• “AI can only do so much unless it’s integrated... That’s really where we see some of the future of letting the technology do some of the work.” (Eric Huckins, 07:06)
• “To maximize success and speed to innovation, you need to find a strong partner...aligned incentives with both the health system and the patient.” (Eric Huckins, 09:35)

Timestamps of Key Segments

• 00:21: Eric Huckins introduces himself and Lumicera’s mission.
• 02:05: Discussion on specialty pharmacy trends and direct-to-consumer models.
• 04:30: Impact of the Inflation Reduction Act and the role of analytics.
• 05:39: Real-world example of prepping for IRA’s MFP-priced drugs.
• 06:53: Technology, AI, and home infusion as future opportunities.
• 09:28: Closing thoughts on partnership and collaboration.

Final Takeaways

• Specialty pharmacy is rapidly evolving with new therapies and business models.
• Policy changes are creating significant operational and financial pressures, requiring proactive analytics and strategy.
• Technology integration and home infusion innovations are key areas of investment and opportunity.
• Strong, philosophically aligned partnerships are essential for scaling success and maintaining patient-centric care in specialty pharmacy.
• Industry collaboration and networking are vital for shared learning and innovation.